Blog Image

The ISBGroup Blog

About the blog

Here you can read about everything that's happening in the ISB Group.

ISB Group as part of the Strategic Research Area in Forensic Sciences

Events, News Posted on Mon, November 09, 2026 13:26:14

Forensic research is a big part of ISB Group’s everyday work. Our colleagues Ralph E. C. Monte and Elin Nyman are part of the Strategic Research Area in Forensic Sciences (SoFo), which is a joint initiative between Linköping University (LiU) and Sweden’s National Board of Forensic Medicine (RMV), combining LiU’s forensic research expertise with RMV’s national laboratory capabilities in forensic genetics and toxicology. Its goals are to produce internationally excellent research, expand forensic science into new areas, strengthen collaboration and research infrastructure, and maintain a creative research environment across the two organizations.

Elin and Ralph attended the annual SoFo meeting at Rimforsa Strand, which began with lunch on the 22nd of October and concluded with lunch on the 23rd. The two days were filled with interesting talks showcasing research in areas such as digital forensics, computer vision and learning systems, forensic toxicology, and forensic genetics. An overarching theme was the development of research and methods to address a wide range of forensic questions.

The meeting also highlighted the need for inter-institutional collaboration and the benefits of bringing different areas of expertise together within a strategic research area such as SoFo. Through its seed grants, SoFo has supported promising research projects and helped foster new collaborations.

There was also ample time for networking, including an evening sauna by the lake, with the option of a refreshing dip! These social activities are important not only for maintaining existing relationships but also for establishing new connections and collaborations. Overall, this year’s annual meeting was a great success, and we are already looking forward to the next one!

View over Rimsforsa Strand captured by Ralph Monte


Gunnar Cedersund and M4-HEALTH Contribute to Europe’s Vision for Virtual Human Twins

Events, M4-HEALTH, News Posted on Mon, November 09, 2026 13:13:53

In October, Gunnar Cedersund, Scientific Coordinator of M4-HEALTH, took part in meetings in Brussels focused on the European Commission’s Advanced Virtual Human Twins initiative.

The initiative aims to establish a shared computational platform where researchers can upload models, combine them with data and run simulations to advance digital twin technology in healthcare. The platform could become an important foundation for future European research projects as well as for medical practice.

During this meeting, we discussed how to align this European initiative and computational platform with the M4-HEALTH network. One of the main contributions of the M4-HEALTH network will be to look more closely at how to combine different sub-models with each other into an interconnected model for the body as a whole. This is not something that is at focus on the European Commission’s Virtual Twin initiative, but it lies at the heart of M4-HEALTH – more specifically, this integration concerns the lower green part of the figure below, and all arrows going into the digital twin.

Explore the details of the meeting in retrospect.



2-day hackathon on development of the core digital twin technology

Events, News Posted on Mon, November 09, 2026 13:10:23

October was a busy time for ISB Group. Among other events, we had a two-day hackathon with focus on innovation and collaboration of the core digital twin technology.

The hackathon brought together expertise in artificial intelligence, mathematical modelling, digital health and software development to explore how research can be translated into practical healthcare applications.

Discussions covered a wide range of topics, including large language models (LLMs) and AI agents, rehabilitation apps, health conversation tools and the development of educational videos featuring digital twins.

After the Hachathon, our Integrative Systems Biology research group had an internal retreat, where we shared existing prototypes, explored technical challenges and discussed how to integrate models, data, visualizations and user experiences into a coherent digital health ecosystem. Topics ranged from exercise physiology, thought modelling and drug development to Parkinson’s disease, rehabilitation and AI-based analysis tools.

By bringing researchers and developers together, the hackathon, and the ensuing retreat, helped turn shared ideas into concrete discussions about the priorities and next steps towards more integrated, data-driven and personalized healthcare.



Further development of ISB Group’s American collaborations in AI and Digital Human Modelling

Events, M4-HEALTH, News Posted on Mon, November 09, 2026 13:01:00

In October, Gunnar Cedersund, ISB Group Leader and Scientific Coordinator of M4-HEALTH, visited two research groups Dura-Bernal Lab and Biodynamics Lab – both M4-HEALTH collaborators – in New York to discuss developments in computational modelling, AI and digital health.

At the Dura-Bernal Lab, discussions focused on the growing use of AI agents in computational neuroscience, with potential applications in e-health and Parkinson’s disease.

At the Biodynamics Lab led by Dr Alex Zhou at the New Jersey institute of Technology (NJIT), Gunnar and Alex discussed the possible applications of their advanced biomechanical models of the human body, including muscles, joints and human–robot interaction. These models could help improve our understanding of movement difficulties and support the development of exoskeletons. These biomechanical models will be of great value in e.g. the neighboring STRATIF-AI project, where we use digital twins to visualize and analyze movements in connection to stoke rehabilitation. In M4-HEALTH, this new technology will also have applications in e.g. movement analysis of athletes, for personal trainers, for physiotherapists, etc.

Both visits highlighted the potential of combining AI, computational modelling and human physiology to develop more accurate digital models and advance personalized healthcare.

Explore the Biodynamics lab

Explore the Dura-Bernal Lab



The Future of Drug Development – M4-HEALTH and ISB Group’s hybrid digital twins in the USA

Events, M4-HEALTH, News Posted on Mon, November 09, 2026 13:00:38

Gunnar Cedersund – Scientific Coordinator of M4-HEALTH was invited to give a lecture about hybrid digital twins and M4-HEALTH at the American Conference on Pharmacometrics (ACoP 2026). At ACoP 2026, one of the major US conferences in pharmacometrics, around 1,000 participants from academia and industry gathered to discuss how modelling and simulation are transforming drug development. New knowledge-driven drug development is central to M4-HEALTH and we have a dedicated sub-cluster M4-Drug Development. The basis for this new approach was recently published earlier this year in European Journal of Pharmaceutical Sciences.

Read the article here

At the heart of this new approach lies not only digital twins but also microphysiological systems: technologies that recreate aspects of human organs in miniature, such as organ-on-a-chip models. Researchers and industry representatives, including Gunnar Cedersund and a team from AstraZeneca in the US, presented approaches combining these systems with computer models to predict drug toxicity and adverse effects.

The potential is significant. According to results presented at the conference, traditional animal models showed limited predictive ability in a particular comparison, while a combined approach using microphysiological and computational models achieved approximately 95% predictive accuracy. These approaches could help reduce reliance on animal experiments while improving predictions of how medicines affect humans.

Another major theme was the growing role of AI agents in pharmacometrics. Multiple sessions focused on how AI agents can contribute to pharmacological modelling and become part of scientific decision-making. But greater autonomy also brings new demands: models and AI-driven processes must be reproducible, validated and open to scrutiny.

The US Food and Drug Administration (FDA) also addressed developments in this area, reflecting the growing importance of establishing appropriate frameworks for using AI in drug development.

The key takeaway: The future of drug development lies not in a single technology, but in combining biological models, computational simulations and AI. The challenge is to make these approaches not only powerful, but also reliable and transparent enough to support real-world decisions about medicines.



Interviews with M4-HEALTH stakeholders

M4-HEALTH, News Posted on Mon, November 09, 2026 12:59:01

M4-HEALTH and ISB Group Head of Communications Katja Woxell is now touring around Linköping, Stockholm, Gothenburg, Lund and Malmö, interviewing some of the prominent M4-HEALTH stakeholders – cancer researchers, toxicologists and forensic experts, experts in systems pharmacology, experts in food industry as well as experts in physical training and community building for preventive healthcare.

M4-CANCER

In mid-October, she interviewed Linda Bojmar and Constantinos Zambirinis – two top-level translational cancer researchers at Linköping University who have discovered microscopic changes occurring in the liver that can be used to predict if, and where, pancreatic cancer may spread in the body. Constantinos and Linda’s research as well as Constantinos’ practical healthcare perspective as a surgical oncologist power the M4-HEALTH sub-cluster M4-Cancer.

We interviewed Linda and Constantinos about their research and its relevance to M4-HEALTH as well as about their newly submitted EU application which plans on full integration of our medical digital twins in their cancer research.

M4-SENIORS

Later that week, Katja Woxell traveled to Stockholm and interviewed Johan Holmsäter – Founder of Friskis & Svettis. Johan is a key actor in the sub-cluster M4-SENIORS and has developed a healthcare program ”Livshanteringsprogrammet” which is being implemented by Norlandia – one of Europe’s largest elderly care companies – along with our hybrid digital twins.

The interviews are in the post-production process and will be released soon on our website and on social media.



Sweden’s health now and in the future: M4-HEALTH at HEALTH HUB

M4-HEALTH, News Posted on Mon, November 09, 2026 12:54:41

Where there is prevention, there is M4-HEALTH.

On October 13, it was time for HEALTH HUB – an annual event that brings together business leaders, researchers, healthcare professionals and decision-makers to focus on preventive healthcare.

For the second year in a row Gunnar Cedersund – ISB Group Leader and Scientific Coordinator of M4-HEALTH – was a speaker at this event and the audience kept cheering on him as he was presenting M4-HEALTH, hybrid digital twins and M4-HEALTH ecosystem-based approach to healthcare. Of course, the presentation also led to several requests for collaboration with M4-HEALTH, and we are looking forward to taking up those discussions.

The event was a celebration of enthusiasm, knowledge and courage to do one’s bit in moving towards a preventive healthcare ecosystem: The speakers covered a wide range of topics, from systematic approaches to workplace health to the chain reactions between different organs, including the role of oral health. They also explored how we can move from a metabolic pandemic towards more healthy years filled with sustained energy, and highlighted the importance of social relationships for well-being, motivation and preventing a collapse by helping recognize the warning signs early. All in all, a series of thought-provoking and inspirational talks!

M4-HEALTH is a proud participant of HEALTH HUB by HOLISTAL. Holistal, together with Oskar Halling Ullberg and Dr. Mouna Esmaeilzadeh that Gunnar shared stage with, are a part of M4-HEALTH. We are looking forward to working with our colleagues towards shared healthcare goals as well as looking forward to getting to know all the companies and people that approached us with collaboration ideas during and after the event.

Many thanks to Holistal CEO Birgitta Thörn for this fruitful event.



Digital Twins at the Lund Engineering Health Annual Meeting

Uncategorised Posted on Tue, September 22, 2026 22:51:42

Today I, Gunnar Cedersund, held the final keynote presentation at the Lund Engineering Health annual meeting. The audience featured engineers, medical doctors, physicists and other disciplines connected to biomedical engineering and health. The topic of this year’s conference was Sustainability, i.e. connections between health and the environment, climate, pollutants, social interactions, etc. It was fun to think about how our digital twins can contribute to those broader questions, and my presentation was followed by quite a lot of discussion and questions, which even continued on the train ride home afterwards. As usual, the core of the presentation was our 25 years of building up these twins, as well as ongoing implementations and trials we do in the M4-HEALTH and STRATIF-AI networks.

Thanks for inviting me, and for giving me the honor of giving the final keynote, ending the entire event!



Next »